Article info

PDF

Original research article
Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers

Authors

  1. Correspondence to Dr Raj Tummala; Raj.Tummala{at}astrazeneca.com
View Full Text

Citation

Tummala R, Rouse T, Berglind A, et al
Safety, tolerability and pharmacokinetics of subcutaneous and intravenous anifrolumab in healthy volunteers

Publication history

  • Received November 10, 2017
  • Revision received February 5, 2018
  • Accepted February 15, 2018
  • First published March 23, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.